×

Not all bad news with Trump pharma meeting?

3:06 PM ET Tue, 31 Jan 2017

Michael Yee, RBC Capital Markets biotech analyst, discusses President Trump's drug pricing rhetoric and his meeting with pharma leaders. CNBC's Meg Tirrell weighs in.